Showing results (11-20 of 74) with videos related to

Sort By:
Pageof 8
Biochemical Pharmacology|July 12, 2008
Erlotinib and gefitinib for the treatment of myelodysplastic syndrome and acute myeloid leukemia: a preclinical comparisonSimone Boehrer, Lionel Adès, Lorenzo Galluzzi, et al.
European Journal of Haematology|November 22, 2007
Synchronous FIP1L1-PDGFRA-positive chronic eosinophilic leukemia and T-cell lymphoblastic lymphoma: a bilineal clonal malignancyMathieu Capovilla, Jean-Michel Cayuela, Chrystèle Bilhou-Nabera, et al.
Cancer|February 10, 2010
Which AML subsets benefit from leukemic cell priming during chemotherapy? Long-term analysis of the ALFA-9802 GM-CSF studyXavier Thomas, Emmanuel Raffoux, Aline Renneville, et al.
Haematologica|April 5, 2011
Impact of post-remission therapy in patients aged 65-70 years with de novo acute myeloid leukemia: a comparison of two concomitant randomized ALFA trials with overlapping age inclusion criteriaRaphael Itzykson, Claude Gardin, Cécile Pautas, et al.
Leukemia Research|December 2, 2011
Minimal residual disease monitoring based on FLT3 internal tandem duplication in adult acute myeloid leukemiaEmna Abdelhamid, Claude Preudhomme, Nathalie Helevaut, et al.
American Journal of Hematology|November 11, 2011
Fractionated doses of gemtuzumab ozogamicin with escalated doses of daunorubicin and cytarabine as first acute myeloid leukemia salvage in patients aged 50-70-year old: a phase 1/2 study of the acute leukemia French associationHassan Farhat, Oumedaly Reman, Emmanuel Raffoux, et al.
Biochemical Pharmacology|June 14, 2011
Tyrosine kinase inhibitors for the treatment of acute myeloid leukemia: delineation of anti-leukemic mechanisms of actionElodie Lainey, Sylvain Thépot, Cyrielle Bouteloup, et al.
Leukemia Research|December 29, 2020
Synergy of FLT3 inhibitors and the small molecule inhibitor of LIM kinase1/2 CEL_Amide in FLT3-ITD mutated Acute Myeloblastic Leukemia (AML) cellsHanane Djamai, Jeannig Berrou, Mélanie Dupont, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|September 28, 2004
Efficacy of granulocyte and granulocyte-macrophage colony-stimulating factors in the induction treatment of adult acute lymphoblastic leukemia: a multicenter randomized studyXavier Thomas, Jean-Michel Boiron, Françoise Huguet, et al.
Haematologica|October 8, 2008
Risk factors and decision criteria for intensive chemotherapy in older patients with acute myeloid leukemiaJean-Valère Malfuson, Anne Etienne, Pascal Turlure, et al.
Pageof 8